World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025
Award Badge
Immunology
France
2026

D-Index & Metrics

Best Female Scientists

D-Index
162
Citations
142608
World Ranking
91
National Ranking
1

Immunology

D-Index
164
Citations
156044
World Ranking
66
National Ranking
3

Medicine

D-Index
164
Citations
156063
World Ranking
642
National Ranking
14

Laurence Zitvogel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Laurence Zitvogel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 595 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Laurence Zitvogel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Laurence Zitvogel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 164 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in France Leader Award
  • 2025 - Research.com Best Female Scientists Award
  • 2025 - Research.com Immunology in France Leader Award
  • 2023 - Research.com Immunology in France Leader Award
  • 2023 - Research.com Medicine in France Leader Award
  • 2022 - Research.com Immunology in France Leader Award
  • 2022 - Research.com Medicine in France Leader Award
  • 2017 - Member of Academia Europaea

Overview

Laurence Zitvogel is affiliated with the University of Paris-Saclay in France. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology. Within these fields, their work is notably concentrated on oncology, molecular biology, immunology, infectious diseases, and pulmonary and respiratory medicine.

The scientist has a substantial publication record addressing several main topics, including cancer immunotherapy and biomarkers, gut microbiota and health, immunotherapy and immune responses, immune cell function and interaction, Clostridium difficile and Clostridium perfringens research, pancreatic and hepatic oncology research, and CAR-T cell therapy research.

Frequent co-authors with whom Laurence Zitvogel has collaborated include Guido Kroemer, Lisa Derosa, Marine Fidelle, Carolina Alves Costa Silva, and Nicola Segata.

They publish frequently in a range of scientific venues, with multiple papers appearing in OncoImmunology, Journal of Clinical Oncology, Nature Medicine, Cancer Discovery, and Cancer Research.

Among their recent papers are:

  • "Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors," 2020, Nature Reviews Clinical Oncology
  • "The microbiome and human cancer," 2021, Science
  • "Immunogenic cell stress and death," 2022, Nature Immunology
  • "Consensus guidelines for the definition, detection and interpretation of immunogenic cell death," 2020, Journal for ImmunoTherapy of Cancer
  • "Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19," 2020, Cell

Laurence Zitvogel's contributions to cancer immunotherapy research and related fields have been recognized by their election as a member of Academia Europaea in 2017.

Best Publications

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Exosomes: composition, biogenesis and function

    Clotilde Théry;Laurence Zitvogel;Sebastian Amigorena

  • Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy;Bertrand Routy;Bertrand Routy;Lisa Derosa;Lisa Derosa;Lisa Derosa;Connie P. M. Duong;Connie P. M. Duong

  • Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    V. Gopalakrishnan;V. Gopalakrishnan;C. N. Spencer;C. N. Spencer;L. Nezi;A. Reuben

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage

  • Calreticulin exposure dictates the immunogenicity of cancer cell death

    Michel Obeid;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;François Ghiringhelli;François Ghiringhelli;François Ghiringhelli;Gian Maria Fimia

  • Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid

  • Immunogenic Cell Death in Cancer Therapy

    Guido Kroemer;Lorenzo Galluzzi;Oliver Kepp;Laurence Zitvogel

  • Innate or Adaptive Immunity? The Example of Natural Killer Cells

    Eric Vivier;David H. Raulet;Alessandro Moretta;Michael A. Caligiuri

  • Immunogenic cell death in cancer and infectious disease

    Lorenzo Galluzzi;Aitziber Buqué;Oliver Kepp;Laurence Zitvogel

  • Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

    Laurence Zitvogel;Armelle Regnault;Anne Lozier;Joseph Wolfers

  • Antigen Presentation and T Cell Stimulation by Dendritic Cells

    Pierre Guermonprez;Jenny Valladeau;Laurence Zitvogel;Clotilde Théry

  • The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

    Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki

  • The immune contexture in cancer prognosis and treatment

    Wolf H Fridman;Laurence Zitvogel;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Guido Kroemer

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Immunological aspects of cancer chemotherapy.

    Laurence Zitvogel;Lionel Apetoh;Lionel Apetoh;François Ghiringhelli;Guido Kroemer;Guido Kroemer

  • Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

    Joseph Wolfers;Anne Lozier;Graça Raposo;Armelle Regnault

  • Cancer despite immunosurveillance: immunoselection and immunosubversion

    Laurence Zitvogel;Antoine Tesniere;Guido Kroemer

  • Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

    Noelia Casares;Marie O. Pequignot;Antoine Tesniere;François Ghiringhelli

  • Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.

    Lorenzo Galluzzi;Aitziber Buqué;Oliver Kepp;Laurence Zitvogel

  • Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

    François Ghiringhelli;Cedric Menard;Pierre Emmanuel Puig;Sylvain Ladoire

Frequent Co-Authors

Guido Kroemer
Guido Kroemer Université Paris Cité
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Erika Vacchelli
Erika Vacchelli Université Paris Cité
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Nathalie Chaput
Nathalie Chaput Institut Gustave Roussy
Fabrice Andre
Fabrice Andre Institut Gustave Roussy
Yuting Ma
Yuting Ma University of Oxford
Takahiro Yamazaki
Takahiro Yamazaki Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related degrees in healthcare can offer diverse career opportunities. Many students begin with accelerated online nursing programs that provide a fast track into nursing roles. Programs like 12-month accelerated nursing programs allow students, including those transitioning from different fields, to quickly gain their Bachelor of Science in Nursing (BSN).

Non-nurses looking to step into the nursing profession can explore the best online BSN programs for non nurses. These programs provide a strong foundation for further specialization in areas such as immunology-related nursing care.

For experienced nurses aiming to expand their scope, accelerated pathways like accelerated RN to NP programs offer an efficient route to becoming nurse practitioners specializing in complex patient care. Furthermore, nurses can advance by enrolling in an FNP to ACNP bridge program online, transitioning from Family Nurse Practitioner roles to Acute Care Nurse Practitioner positions.

These pathways highlight how online programs cater to different stages of nursing careers, ultimately supporting roles that intersect with immunology in clinical and research settings.

Best Scientists Citing Laurence Zitvogel

Trending Scientists

Recently Published Articles